HEALTH GUIDES
Cosmetic Surgery Cosmetic Dentistry Family Health Health Insurance Laser Eye Surgery Life Insurance Travel HealthMEDICAL A TO Z
Alternative Medicine Blood Disorders Cancer Dental Disorders Diabetes Digestive Disorders Ear & Hearing Disorders Endocrine Disorders Eye Disorders Genetic Disorders Heart Disorders Infectious Diseases Kidney Disorders Lung Disorders Mental Health Neurological Disorders Skin, Bone & Muscle Disorders Sleep DisordersTOPICS/THEMES
Allergies Alternative Health Arthritis Asthma Blood Disorders Bones & Joints Bowel & Abdominal Problems Cancer Chest Problems Child Health Circulation Problems Diabetes Diet & Nutrition Drug Addiction Ear, Nose, & Throat Problems Elderly Health Eye Problems Heart Problems High Blood Pressure Hormone & Endocrine Problems Infections Infertility Liver Problems Medications Men's Health Mental Health Nervous System Personal & Social Issues Pregnancy & Birth Preventive Health Radiology Sexual Health Skin Problems Sports Medicine Surgery Travel Health Urinary & Kidney Problems Vaccination Women's HealthMISCELLANEOUS
Medic8 Search Terms Of Use About Medic8Ibandronic acid (INN) or ibandronate sodium (USAN), marketed under the trade names Boniva®, Bondronat® and Bonviva®, is a potent bisphosphonate drug used in the prevention and treatment of osteoporosis. It may also be used to treat hypercalcemia (elevated blood calcium levels).
Indications
Ibandronate is indicated for the treatment and prevention of osteoporosis in postmenopausal women. Ibandronate was approved by the U.S. Food and Drug Administration (FDA) in May 2003 as a 2.5 mg daily treatment for postmenopausal osteoporosis. The basis for this approval was a 3-year, randomized, double-blind, placebo-controlled trial of 2,946 women with postmenopausal osteoporosis. Participants in this study received placebo or oral ibandronate either daily (2.5 mg) or intermittently (20 mg every other day for 12 doses at the start of each 3-month interval). All study participants also received 500 mg of oral calcium and 400 international units of vitamin D daily. At the conclusion of the study, both doses significantly reduced the risk of new vertebral fractures by 50% to 52% when compared to placebo.
Medic8® Medicines
Page last modified: May 2007
DISCLAIMER: This website/guide is provided for general information only and is not a substitute for professional medical advice. We are not responsible or liable for any diagnosis or action made by a user based on the content of this website. We are not liable for the contents of any external websites listed, nor do we endorse any commercial product or service mentioned or advised on any of the sites. Always consult your own doctor if you are in any way concerned about your health.
LEGAL CONDITIONS AND TERMS OF USE ARE APPLICABLE TO ALL USERS OF THIS GUIDE/WEBSITE. ANY USE OF THIS GUIDE CONSTITUTES YOUR AGREEMENT TO THESE TERMS OF USE. REPRODUCTION OF ANY PART OF THIS WEBSITE BY ANY MEANS, INCLUDING ELECTRONIC, IS EXPRESSLY PROHIBITED WITHOUT PRIOR WRITTEN CONSENT.
www.medic8.com
© Medic8 ® All Rights Reserved.
- Medic8 - Health Guide - Mortgage Guide - A to Z - Medical Dictionary - Terms Of Use - Privacy - About -